174 related articles for article (PubMed ID: 38458796)
21. Metastatic breast cancer incidence, site and survival in Australia, 2001-2016: a population-based health record linkage study protocol.
Lord SJ; Kiely BE; Pearson SA; Daniels B; O'Connell DL; Beith J; Bulsara MK; Houssami N
BMJ Open; 2019 Feb; 9(2):e026414. PubMed ID: 30709862
[TBL] [Abstract][Full Text] [Related]
22. Calcium channel blockers in hypertension: reappraisal after new trials and major meta-analyses.
Opie LH
Am J Hypertens; 2001 Oct; 14(10):1074-81. PubMed ID: 11710789
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a Common Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older Adults With Hypertension.
Savage RD; Visentin JD; Bronskill SE; Wang X; Gruneir A; Giannakeas V; Guan J; Lam K; Luke MJ; Read SH; Stall NM; Wu W; Zhu L; Rochon PA; McCarthy LM
JAMA Intern Med; 2020 May; 180(5):643-651. PubMed ID: 32091538
[TBL] [Abstract][Full Text] [Related]
24. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
25. Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker-Induced Lower-Extremity Edema With Loop Diuretics.
Vouri SM; Jiang X; Manini TM; Solberg LM; Pepine C; Malone DC; Winterstein AG
JAMA Netw Open; 2019 Dec; 2(12):e1918425. PubMed ID: 31880802
[TBL] [Abstract][Full Text] [Related]
26. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women.
Fitzpatrick AL; Daling JR; Furberg CD; Kronmal RA; Weissfeld JL
Cancer; 1997 Oct; 80(8):1438-47. PubMed ID: 9338468
[TBL] [Abstract][Full Text] [Related]
27. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
Colditz GA
Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
[TBL] [Abstract][Full Text] [Related]
28. Use of calcium channel blockers and risk of breast cancer among women aged 55 years and older: a nationwide population-based cohort study.
Lin SY; Huang HY; Chiang LT; Huang LY; Wang CC
Hypertens Res; 2023 Oct; 46(10):2272-2279. PubMed ID: 37253976
[TBL] [Abstract][Full Text] [Related]
29. Artificial intelligence (AI) to enhance breast cancer screening: protocol for population-based cohort study of cancer detection.
Marinovich ML; Wylie E; Lotter W; Pearce A; Carter SM; Lund H; Waddell A; Kim JG; Pereira GF; Lee CI; Zackrisson S; Brennan M; Houssami N
BMJ Open; 2022 Jan; 12(1):e054005. PubMed ID: 34980622
[TBL] [Abstract][Full Text] [Related]
30. The calcium channel blocker controversy in perspective.
Zanchetti A
Cardiology; 1997; 88 Suppl 1():66-70; discussion 71-2. PubMed ID: 9118170
[TBL] [Abstract][Full Text] [Related]
31. Protocol for a national cohort study to explore the long-term clinical and patient-reported outcomes and cost-effectiveness of implant-based and autologous breast reconstruction after mastectomy for breast cancer: the brighter study.
Johnson L; Holcombe C; O'Donoghue JM; Jeevan R; Browne J; Fairbrother P; MacKenzie M; Gulliver-Clarke C; White P; Mohiuddin S; Hollingworth W; Potter S
BMJ Open; 2021 Aug; 11(8):e054055. PubMed ID: 34408062
[TBL] [Abstract][Full Text] [Related]
32. Association of calcium channel blockers with lower incidence of intracranial aneurysm rupture and growth in hypertensive patients.
Liu Q; Li J; Zhang Y; Leng X; Mossa-Basha M; Levitt MR; Wang S; Zhu C
J Neurosurg; 2023 Sep; 139(3):651-660. PubMed ID: 36708539
[TBL] [Abstract][Full Text] [Related]
33. Breast screening atypia and subsequent development of cancer: protocol for an observational analysis of the Sloane database in England (Sloane atypia cohort study).
Jenkinson D; Freeman K; Clements K; Hilton B; Dulson-Cox J; Kearins O; Stallard N; Wallis MG; Sharma N; Kirwan C; Pinder S; Provenzano E; Shaaban AM; Stobart H; McDonnell S; Thompson AM; Taylor-Phillips S
BMJ Open; 2022 Jan; 12(1):e058050. PubMed ID: 34996804
[TBL] [Abstract][Full Text] [Related]
34. Protective Association Between Calcium Channel Blocker Use and Breast Cancer Recurrence in Postsurgical Women: A Population-Based Case-Control Study in Taiwan.
Shih JH; Kao LT; Chung CH; Liao GS; Fann LY; Chien WC; Li IH
J Clin Pharmacol; 2020 Jun; 60(6):785-792. PubMed ID: 32020656
[TBL] [Abstract][Full Text] [Related]
35. Meta-Analysis Evaluating Calcium Channel Blockers and the Risk of Peripheral Arterial Disease in Patients With Hypertension.
Shetty S; Malik AH; Feringa H; El Accaoui R; Girotra S
Am J Cardiol; 2020 Mar; 125(6):907-915. PubMed ID: 31959429
[TBL] [Abstract][Full Text] [Related]
36. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
37. Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the Department of Health Hypertension Care Computing Project (DHCCP).
Bulpitt CJ; Palmer AJ; Beevers DG; Coles EC; Ledingham JG; Petrie JC; Webster J
J Hum Hypertens; 1997 Apr; 11(4):205-11. PubMed ID: 9185024
[TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer Outcomes in people with Severe Mental Illness Cohort (COSMIC): a protocol for an Australian retrospective cohort using linked administrative data.
Protani MM; Jordan SJ; Kendall BJ; Siskind D; Lawrence D; Sara G; Brophy L; Kisely S
BMJ Open; 2021 Jun; 11(6):e044737. PubMed ID: 34103315
[TBL] [Abstract][Full Text] [Related]
39. Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study.
Beiderbeck-Noll AB; Sturkenboom MC; van der Linden PD; Herings RM; Hofman A; Coebergh JW; Leufkens HG; Stricker BH
Eur J Cancer; 2003 Jan; 39(1):98-105. PubMed ID: 12504665
[TBL] [Abstract][Full Text] [Related]
40. Risk of Developing Hypokalemia in Patients With Hypertension Treated With Combination Antihypertensive Therapy.
Krogager ML; Mortensen RN; Lund PE; Bøggild H; Hansen SM; Kragholm K; Aasbjerg K; Søgaard P; Torp-Pedersen C
Hypertension; 2020 Apr; 75(4):966-972. PubMed ID: 32114850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
